IGF::OT::IGF: IN-HOME DEACTIVATION SYSTEM FOR PSYCHOACTIVE DRUGS. N43DA-13-4420.
$149,162N43FY2013DANIH
Investigators
Abstract
Under this Small Business Innovation Research (SBIR) Phase I project, Reasearch Topic 148, the Contractor will develop an inexpensive in-home product for rapid and safe at-source deactivation of discarded psychoactive pharmaceuticals.
View original record on NIH RePORTER →